CLINICAL TRIAL SUMMARY

MDACC Study No:2012-0584 (clinicaltrials.gov NCT No: NCT01739634)
Title:The efficacy of CASAD in patients with diarrhea related to medullary thyroid cancer: a pilot study
Principal Investigator:Maria E. Cabanillas
Treatment Agent:CASAD
Study Status:Closed
Study Description:The goal of this clinical research study is to learn if calcium
alumino-silicate anti-diarrheal (CASAD) can help to control diarrhea in
patients with MTC.

CASAD is designed to block the actions of certain toxins that may cause
diarrhea.

Hide details for General InformationGeneral Information

Disease Group:Thyroid
Phase of Study:N/A
Treatment Agents:CASAD
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:
Supported By:Salient Pharmaceuticals
Return Visit:
Home Care:


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Maria E. Cabanillas
Dept:Endocrine Neoplasia & Hormonal Disorders
For Clinical Trial Enrollment:713-792-2841
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults